Westenberg H G, Gerritsen T W, Meijer B A, van Praag H M
Psychiatry Res. 1982 Dec;7(3):373-85. doi: 10.1016/0165-1781(82)90074-9.
The kinetics of l-5-hydroxytryptophan (5-HTP) were studied in five volunteers after intravenous and oral administration of 5-HTP following pretreatment with carbidopa. In addition, the effect of pretreatment with carbidopa on metabolism and disposition of 5-HTP was studied in eight subjects. The kinetics of 5-HTP following a 20-minute linear infusion are adequately described by a biexponential function. The biological half-life of 5-HTP ranged from 2.2 to 7.4 hours, and the plasma clearance ranged from 0.10 to 0.23 1/kg/hour. The bioavailability of 5-HTP after oral administration in combination with carbidopa was calculated as 48% +/- 15 (mean +/- SD). The plasma concentrations of 5-HTP observed in this study displayed an unusual double peak in most subjects after oral administration. Pretreatment with carbidopa caused a significant increase in the extent of absorption of unchanged 5-HTP, and a significant reduction in the area under the plasma concentration-time curves of 5-hydroxyindoleacetic acid. Gastrointestinal side effects appeared to be related to the 5-HTP plasma concentration.
在五名志愿者中,研究了在使用卡比多巴预处理后静脉注射和口服L-5-羟色氨酸(5-HTP)后的动力学。此外,在八名受试者中研究了卡比多巴预处理对5-HTP代谢和处置的影响。静脉滴注20分钟后5-HTP的动力学可用双指数函数充分描述。5-HTP的生物半衰期为2.2至7.4小时,血浆清除率为0.10至0.23升/千克/小时。口服5-HTP与卡比多巴联合使用后的生物利用度计算为48%±15(平均值±标准差)。在本研究中观察到,大多数受试者口服后5-HTP的血浆浓度出现异常双峰。卡比多巴预处理导致未改变的5-HTP吸收程度显著增加,5-羟吲哚乙酸血浆浓度-时间曲线下面积显著减少。胃肠道副作用似乎与5-HTP血浆浓度有关。